Mutations in the gene result in Nijmegen breakage syndrome (NBS), and the gene encodes NBS1 that forms a complex with MRE11 and RAD50 and participates in DNA damage repair. However, the molecular mechanism by which mutations cause clinical phenotypes of NBS, such as craniofacial dysmorphism, is still unclear. Here, we show that NBS1 localizes at the ribosomal DNA (rDNA) loci in nucleoli and interacts with ribosomal RNA (rRNA) transcription machinery including RNA polymerase I (Pol I) and TCOF1. Loss of NBS1 impairs Pol I-dependent transcription of pre-rRNA and induces nucleolar stress. In particular, lacking Nbs1 in mouse neural crest cells not only leads to the reduction of ribosome biogenesis but also craniofacial abnormalities during prenatal development. Moreover, the C-terminus of NBS1 is associated with pre-rRNA and a number of pre-rRNA processing factors, which may also facilitate pre-rRNA maturation. Taken together, our study reveals the functions of NBS1 in rRNA biogenesis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1073/pnas.2422029122 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
NBS1 facilitates preribosomal RNA biogenesis.
Proc Natl Acad Sci U S A
March 2025
Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang 310030, China.
Mutations in the gene result in Nijmegen breakage syndrome (NBS), and the gene encodes NBS1 that forms a complex with MRE11 and RAD50 and participates in DNA damage repair. However, the molecular mechanism by which mutations cause clinical phenotypes of NBS, such as craniofacial dysmorphism, is still unclear. Here, we show that NBS1 localizes at the ribosomal DNA (rDNA) loci in nucleoli and interacts with ribosomal RNA (rRNA) transcription machinery including RNA polymerase I (Pol I) and TCOF1.
View Article and Find Full Text PDFFibroblast-based radiosensitivity assays as a clinically valuable tool for (severe) combined immunodeficiency syndromes.
Mutat Res Genet Toxicol Environ Mutagen
March 2025
Radiobiology Lab, Department of Human Structure and Repair, Ghent University, Ghent, Belgium; Cancer Research Institute Ghent (CRIG), Ghent University Hospital, Ghent 9000, Belgium.
Genetic defects in one of the DNA double strand break (DSB) repair proteins lead to distinct human syndromes with severe clinical manifestations, including impaired neurological and immunological development, cancer proneness and sensitivity to ionizing radiation. Since diagnostic and therapeutic procedures frequently use DNA damaging agents, identification of radiosensitive individuals is imperative to optimize patient management. However, patients with a (severe) combined immunodeficiency (S)CID are often ineligible for lymphocyte-based radiosensitivity testing.
View Article and Find Full Text PDFPLK1 phosphorylates WRN at replication forks.
J Pharmacol Exp Ther
February 2025
Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky; Markey Cancer Center, University of Kentucky, Lexington, Kentucky. Electronic address:
Prostate cancer, particularly castration-resistant prostate cancer, remains a serious public health issue. Androgen signaling inhibitors have emerged as a major treatment approach but with limited success. Thus, identification of novel treatment targets is of high clinical relevance.
View Article and Find Full Text PDFRPUSD1 enhances the expression of eIF4E through RluA catalytic domain, activates PI3K/AKT signaling pathway, and promotes the cell proliferation and invasion in non-small cell lung cancer.
Int J Biol Macromol
February 2025
Department of Pathology, College of Basic Medical Sciences, the First Hospital of China Medical University, Shenyang 110122, PR China. Electronic address:
RNA pseudouridylate synthase domain containing 1 (RPUSD1) is a pseudouridine synthase, and its role in human solid tumors remains unknown. We found that RPUSD1 showed enhanced cytoplasmic expression in non-small cell lung cancer (NSCLC) using immunohistochemistry and western blotting. Its increased expression is associated with tumor malignant phenotypes.
View Article and Find Full Text PDFPhosphorylated BLM peptide acts as an agonist for DNA damage response.
Nucleic Acids Res
February 2025
Biotechnology Research and Innovation Council-National Institute of Immunology (BRIC-NII), Aruna Asaf Ali Marg, New Delhi110067, India.
Upon exposure to ionizing irradiation, the MRE11-RAD50-NBS1 complex potentiates the recruitment of ATM (ataxia-telangiectasia mutated) kinase to the double-strand breaks. We show that the lack of BLM causes a decrease in the autophosphorylation of ATM in mice mammary glands, which have lost one or both copies of BLM. In isogenic human cells, the DNA damage response (DDR) pathway was dampened in the absence of BLM, which negatively affected the recruitment of DDR factors onto the chromatin, thereby indicating a direct role of BLM in augmenting DDR.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!